The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
EGFR expression and relapse in patients with melanoma receiving adjuvant PD-1-based immunotherapy.
 
Teresa Maria Santos Amaral
Honoraria - Novartis
Consulting or Advisory Role - CeCaVa
Research Funding - NeraCare GmbH (Inst); Novartis (Inst); Skyline Diagnostics (Inst)
 
Oltin Tiberiu Pop
No Relationships to Disclose
 
Eftychia Chatziioannou
No Relationships to Disclose
 
Tobias Sinnberg
Research Funding - Novartis (Inst); Pierre Fabre (Inst)
 
Heike Niessner
Research Funding - Novartis; Pierre Fabre
 
Sandra Rim
Patents, Royalties, Other Intellectual Property - Hookipa Pharma
 
Markus Joerger
Consulting or Advisory Role - AstraZeneca (Inst); Basilea Pharmaceutical (Inst); Bristol-Myers Squibb (Inst); InnoMedica (Inst); Merck (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst)
Research Funding - AstraZeneca (Inst); Basilea Pharmaceutical (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo Pharmaceutical (Inst); Immunophotonics (Inst); InnoMedica (Inst); Janssen Oncology (Inst); Lilly O. (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst); Sanofi (Inst); Takeda (Inst)
 
Christopher Schroeder
Research Funding - Bristol-Myers Squibb Stiftung Immunonkologie (Inst)
 
Sorin Armeanu-Ebinger
No Relationships to Disclose
 
Antonio Cozzio
Consulting or Advisory Role - Abbvie; Amgen; Leo Pharma; Lilly O.; Novartis; Sanofi
 
Ulrike M. Leiter
Honoraria - MSD Oncology; MSD Oncology; Novartis; Roche; Sanofi; Sun Pharma
Consulting or Advisory Role - MSD Oncology; Novartis; Roche; Sanofi; Sun Pharma
Research Funding - MSD Oncology
Travel, Accommodations, Expenses - Novartis
 
Wolfram Jochum
Consulting or Advisory Role - Merck
Speakers' Bureau - Merck
Research Funding - AstraZeneca (Inst)
 
Stephan Forchhammer
Honoraria - Kyowa Kirin; Recordati
Research Funding - BioNTech (Inst); NeraCare GmbH (Inst); Skyline Diagnostics (Inst)
 
Mitchell P. Levesque
Stock and Other Ownership Interests - Oncobit
Honoraria - Danaher
Consulting or Advisory Role - Oncobit
Research Funding - Molecular Partners; Novartis; Oncobit; Roche
Patents, Royalties, Other Intellectual Property - EP 22/178503.3
Travel, Accommodations, Expenses - Leica Biosystems
 
Joanna Mangana
Consulting or Advisory Role - Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche
Research Funding - Bristol-Myers Squibb (Inst); MSD (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme; Pierre Fabre
 
Michael Hölzel
Honoraria - Bristol-Myers Squibb; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis
Research Funding - TME Pharma
Travel, Accommodations, Expenses - TME Pharma
 
Reinhard Dummer
Honoraria - Alligator Bioscience; Amgen; Bristol-Myers Squibb; Catalym; MaxiVax ; MSD; Novartis; Pfizer; Pierre Fabre; Regeneron; Roche; Sanofi; Second Genome; Sun Pharma; T3 Pharmaceuticals; Takeda; touchIME
Consulting or Advisory Role - Alligator Bioscience; Amgen; Bristol-Myers Squibb; Catalym; MaxiVax ; MSD; Novartis; Pfizer; Pierre Fabre; Regeneron; Roche; Sanofi; Second Genome; Sun Pharma; T3 Pharmaceuticals; Takeda; touchIME
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Novartis (Inst); Roche (Inst)
 
Christian Schürch
Stock and Other Ownership Interests - Enable Medicine
Research Funding - Enable Medicine
Patents, Royalties, Other Intellectual Property - Stanford University; University of Bern
(OPTIONAL) Uncompensated Relationships - Enable Medicine
 
Andrea Forschner
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Consulting or Advisory Role - Bristol-Myers Squibb; Immunocore; MSD; Novartis; Pierre Fabre
Research Funding - Bristol-Myers Squibb Stiftung Immunonkologie (Inst)
Travel, Accommodations, Expenses - Novartis; Pierre Fabre
 
Lukas Flatz
Consulting or Advisory Role - Philogen; Sanofi
Research Funding - Hookipa Pharma; Philogen
Patents, Royalties, Other Intellectual Property - Patents relating to the Vaxwave Vaccine Technology currently licensed by Hookipa Pharma.